title: Targeting opioid receptors with pharmacological chaperones.
abstract: G protein-coupled receptors (GPCRs) are polytopic membrane proteins that have a pivotal role in cellular signaling. Like other membrane proteins, they fold in the endoplasmic reticulum (ER) before they are transported to the plasma membrane. The ER quality control monitors the folding process and misfolded proteins and slowly folding intermediates are targeted to degradation in the cytosol via the ubiquitin-proteasome pathway. The high efficiency of the quality control machinery may lead to the disposal of potentially functional receptors. This is the major underlying course for loss-of-function conformational diseases, such as retinitis pigmentosa, nephrogenic diabetes insipidus and early onset obesity, which involve mutant GPCRs. During the past decade, it has become increasingly evident that small-molecular lipophilic and pharmacologically selective receptor ligands, called pharmacological chaperones (PCs), can rescue these mutant receptors from degradation by stabilizing newly synthesized receptors in the ER and enhancing their transport to the cell surface. This has raised the interesting prospect that PCs might have therapeutic value for the treatment of conformational diseases. At the same time, accumulating evidence has indicated that wild-type receptors might also be targeted by PCs, widening their therapeutic potential. This review focuses on one GPCR subfamily, opioid receptors that have been useful models to unravel the mechanism of action of PCs. In contrast to most other GPCRs, compounds that act as PCs for opioid receptors, including widely used opioid drugs, target wild-type receptors and their common natural variants.
authors.affiliation: Department of Anatomy and Cell Biology and Medical Research Center Oulu, Institute of Biomedicine, University of Oulu, FI-90014 Oulu, Finland. Electronic address: ulla.petaja-repo@oulu.fi.
authors.forename: Ulla E
authors.initials: UE
authors.lastname: Petäjä-Repo
authors.affiliation: Department of Anatomy and Cell Biology and Medical Research Center Oulu, Institute of Biomedicine, University of Oulu, FI-90014 Oulu, Finland.
authors.forename: Jarkko J
authors.initials: JJ
authors.lastname: Lackman
mesh_terms: D000818:Animals; D055808:Drug Discovery; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D017510:Protein Folding / Q000187:drug effects*; D055550:Protein Stability / Q000187:drug effects; D021381:Protein Transport / Q000187:drug effects; D011957:Receptors, Opioid / Q000032:analysis / Q000378:metabolism*
chemical_list: D008024:Ligands; D011957:Receptors, Opioid
keywords: Endoplasmic reticulum; Opioid receptor; Pharmacological chaperone; Protein folding; Quality control; Up-regulation